NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $141,000 | -28.8% | 11,500 | 0.0% | 0.01% | -31.6% |
| Q3 2016 | $198,000 | -13.2% | 11,500 | -28.1% | 0.02% | -17.4% |
| Q2 2016 | $228,000 | +3.6% | 16,000 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $220,000 | -18.5% | 16,000 | 0.0% | 0.02% | -17.9% |
| Q4 2015 | $270,000 | +45.2% | 16,000 | -5.8% | 0.03% | +40.0% |
| Q3 2015 | $186,000 | -12.3% | 16,985 | 0.0% | 0.02% | -4.8% |
| Q2 2015 | $212,000 | +13.4% | 16,985 | 0.0% | 0.02% | +10.5% |
| Q1 2015 | $187,000 | -28.9% | 16,985 | 0.0% | 0.02% | -34.5% |
| Q4 2014 | $263,000 | +25.8% | 16,985 | -1.8% | 0.03% | +16.0% |
| Q3 2014 | $209,000 | -11.8% | 17,300 | -6.5% | 0.02% | -16.7% |
| Q2 2014 | $237,000 | +12.9% | 18,500 | +6.9% | 0.03% | +7.1% |
| Q1 2014 | $210,000 | +7.1% | 17,300 | 0.0% | 0.03% | +12.0% |
| Q4 2013 | $196,000 | +4.3% | 17,300 | -3.9% | 0.02% | +4.2% |
| Q3 2013 | $188,000 | -19.7% | 18,000 | -11.3% | 0.02% | -25.0% |
| Q2 2013 | $234,000 | – | 20,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |